Diabetics Hold Their Breath for Inhalable Insulin

Your next video will start in

Recommended Videos

  • Info

  • Comments


Sept. 23 (Bloomberg) -- Bloomberg’s Olivia Sterns explores the market for inhalable insulin as Mankind Corporation may be close to bringing the medicine to market after drug makers have failed for years in their pursuit of the product and the potential billions it could bring in. She speaks on Bloomberg Television’s “Market Makers.”

Breakthrough for diabetics, millions of people around the world are walking about every day pretty themselves with needles for in shot of insulin.

I have a prototype here.

It was nicknamed the dreatmm, boat in development, and the problem is that many have tried this, but no one has succeeded yet.

This product,= from mannkind it's in post development.

The other devices were just going for convenience.

They were trying to deliver insulin by avoiding injection.

That is not how ours works, it is all about getting it into the bloodstream.

, money are we talking about?

The demand is growing rapidly.

Type 2 diabetes affects more than 10% of the population here in the u.s. look at how fast rates are growing.

It is just astonishing.

We estimate $500 billion in medical costs for those with diabetes, patients phil about $180 million -- phil -- fill 180 million per script and prayer.

This text has been automatically generated. It may not be 100% accurate.


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change